Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity

Published:2019-06-03 Issue:3 Volume:157 Page:232-247
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Yano Hiroshi¹²^ORCID,Andrews Lawrence P.¹,Workman Creg J.¹,Vignali Dario A. A.¹³⁴^ORCID

Affiliation:

1. Department of Immunology University of Pittsburgh School of Medicine Pittsburgh PA USA

2. Graduate Program in Microbiology and Immunology (PMI) University of Pittsburgh School of Medicine Pittsburgh PA USA

3. Tumor Microenvironment Center UPMC Hillman Cancer Center Pittsburgh PA USA

4. Cancer Immunology and Immunotherapy Program UPMC Hillman Cancer Center Pittsburgh PA USA

Funder

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13067

Reference100 articles.

1. Control of Regulatory T Cell Development by the Transcription Factor Foxp3

2. How regulatory T cells work

3. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

4. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

5. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of dietary Chitosan oligosaccharides supplementation on Th17/Treg balance and gut microbiota of early weaned pigeon squabs;Poultry Science;2024-10

2. Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies;Andrology;2024-09-10

3. Next-generation cancer vaccines and emerging immunotherapy combinations;Trends in Cancer;2024-08

4. PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies;Cell Reports Medicine;2024-07

5. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development;International Journal of Molecular Sciences;2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3